Literature DB >> 10861478

Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types.

M V Jacobs1, J M Walboomers, P J Snijders, F J Voorhorst, R H Verheijen, N Fransen-Daalmeijer, C J Meijer.   

Abstract

Before guidelines can be set for the use of high-risk human papillomavirus (HR HPV) testing in cervical cancer screening and vaccine preparation, age-related prevalence of HR HPV types in cytologically normal smears has to be known. Therefore, in a cross-sectional study the prevalence of 37 different HPV genotypes and putatively unidentified HPV types was determined in 3,305 cytologically normal cervical smears from the general female population (15-69 years of age) using an HPV general primer GP5+/bioGP6+ mediated PCR assay. Subsequently, HPV-positive cervical smears were typed for 19 HR and 18 low-risk (LR) HPVs with an enzyme immunoassay using HPV type-specific oligoprobes in cocktails and individually, respectively. Overall, -HR and -LR HPV prevalences appeared to be of 4.6%, 3.3%, and 1.0%, respectively. Twenty-six different HPV types were detected in the 152 HPV-positive samples, the most prevalent types being HPV 16, 31, and 18. With regard to age, a peak prevalence of 19.6% for all HPVs was found in women 25-29 years of age, which declined to a mean of 4.3% in women over 30 years. With regard cytologically normal cervical smears (n = 3, 011) of women participating in the population-based screening program in the Netherlands (30 to 60 years), all HR HPVs showed decreased occurrence with increasing age, whereas the prevalence of LR HPV types remained constant. We suggest that screening for abnormal cytology implies screening for HR HPV infections and the subsequent treatment results in a decline of HR HPV prevalence in contrast to LR HPV prevalence during the years of screening. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10861478

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  80 in total

1.  High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar Pradesh, India: a population-based study.

Authors:  Shikha Srivastava; Sadhana Gupta; Jagat Kumar Roy
Journal:  J Biosci       Date:  2012-03       Impact factor: 1.826

2.  [Anal HPV infections].

Authors:  Felix Aigner; Friedrich Conrad; Andreas Widschwendter; Robert Zangerle; Bettina Zelger; Alfred Haidenberger; Sebastian Roka; Kurt Heim; Reinhard Höpfl; Martin Klimpfinger; Yves Marcus Rigler; Hugo Bonatti; Johann Pfeifer; Andrea Maier; Reinhard Kirnbauer; Andreas Salat
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

3.  High grade cervical intraepithelial neoplasia and viral load of high-risk human papillomavirus: significant correlations in patients of 22 years old or younger.

Authors:  Yuanchun Xu; Jorge Dotto; Yiang Hui; Kara Lawton; Kevin Schofield; Pei Hui
Journal:  Int J Clin Exp Pathol       Date:  2008-07-25

4.  Prevalence of human papillomavirus in university young women.

Authors:  Maria T Montalvo; Ismelda Lobato; Hilda Villanueva; Celia Borquez; Daniela Navarrete; Juan Abarca; Gloria M Calaf
Journal:  Oncol Lett       Date:  2011-04-06       Impact factor: 2.967

5.  Cervical human papillomavirus infection in accra, ghana.

Authors:  Ab Domfeh; Ek Wiredu; Aa Adjei; Pfk Ayeh-Kumi; Tk Adiku; Y Tettey; Rk Gyasi; Hb Armah
Journal:  Ghana Med J       Date:  2008-06

6.  Role of paan chewing and dietary habits in cervical carcinoma in Chennai, India.

Authors:  T Rajkumar; S Franceschi; S Vaccarella; V Gajalakshmi; A Sharmila; P J F Snijders; N Muñoz; C J L M Meijer; R Herrero
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

7.  Differences in the risk of cervical cancer and human papillomavirus infection by education level.

Authors:  S Franceschi; M Plummer; G Clifford; S de Sanjose; X Bosch; R Herrero; N Muñoz; S Vaccarella
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

8.  Model for assessing human papillomavirus vaccination strategies.

Authors:  Elamin H Elbasha; Erik J Dasbach; Ralph P Insinga
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

9.  HPV infection in women with and without cervical cancer in Conakry, Guinea.

Authors:  N Keita; G M Clifford; M Koulibaly; K Douno; I Kabba; M Haba; B S Sylla; F J van Kemenade; P J F Snijders; C J L M Meijer; S Franceschi
Journal:  Br J Cancer       Date:  2009-06-16       Impact factor: 7.640

10.  Human papillomavirus infection in Honduran women with normal cytology.

Authors:  N Tábora; J M J E Bakkers; W G V Quint; L F A G Massuger; J A Matute; W J G Melchers; A Ferrera
Journal:  Cancer Causes Control       Date:  2009-08-15       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.